公开(公告)号：US20210032374A1

公开(公告)日：2021-02-04

申请号：US16967345

申请日：2019-02-02

申请人： SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD. ,  SOOCHOW UNIVERSITY

发明人： Zhenqing Zhang ,  Naiyu Xu ,  Xiang Yin ,  Li Pang ,  Lulu Shen ,  Jie Xue

IPC分类号： C08B37/00 ,  A61P3/10 ,  A61P3/06

摘要： The present application relates to the field of medicine. The present application relates to an isolated Saposhnikovia divaricata polysaccharide and use thereof in the manufacture of a medicament for treating diabetes mellitus or hyperlipoidemia. In particular, the present application relates to an isolated Saposhnikovia divaricata polysaccharide comprising L-arabinose, D-galacturonic acid, D-mannose, D-glucose and D-galactose, wherein the molar ratio of the L-arabinose: D-galacturonic acid: D-mannose: D-glucose: D-galactose is 1-15:1-10:1-10:10-40:1-15, preferably 1-5:5-10:1-5:20-25:1-5.

公开(公告)号：US20200376021A1

公开(公告)日：2020-12-03

申请号：US16967391

申请日：2019-02-02

申请人： SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD. ,  SOOCHOW UNIVERSITY

发明人： Zhenqing Zhang ,  Naiyu Xu ,  Xiang Yin ,  Li Pang ,  Lulu Shen ,  Jie Xue

IPC分类号： A61K31/715 ,  A61P3/06

摘要： Provided herein are an isolated Imperata cylindrica polysaccharide and use thereof in the manufacture of a medicament for treating hyperlipoidemia. The Imperata cylindrica polysaccharide comprises L-arabinose, D-xylose, D-mannose, D-glucose and D-galactose, wherein the molar ratio of the L-arabinose:D-xylose:D-mannose:D-glucose:D-galactose is 1-20:1-15:1-15:15-40:25-60.